Welcome to our dedicated page for Lemaitre Vasculr news (Ticker: LMAT), a resource for investors and traders seeking the latest updates and insights on Lemaitre Vasculr stock.
LeMaitre Vascular, Inc. provides devices, implants, and services for the treatment of peripheral vascular disease. The company develops, manufactures, and markets disposable and implantable vascular devices for vascular surgeons, with products used in arteries and veins.
Recurring LMAT news includes quarterly financial results, guidance, dividend declarations, and management presentations at healthcare investor conferences. Company updates also discuss product categories such as Artegraft, grafts, valvulotomes, and carotid shunts, along with sales activity across the Americas, EMEA, and Asia Pacific.
LeMaitre Vascular, Inc. (Nasdaq: LMAT) will release its second quarter 2020 financial results on July 23, 2020, after market close. A conference call is scheduled for 5:00 PM EDT to discuss results, business highlights, and company outlook. LeMaitre offers devices and services for peripheral vascular disease, which affects over 200 million people globally. The company specializes in developing disposable and implantable vascular devices, targeting vascular surgeons with its diverse product portfolio.
LeMaitre Vascular, Inc. (Nasdaq: LMAT) announced the acquisition of Artegraft, Inc. for $90 million, which includes $72.5 million in cash and potential earnouts of $17.5 million. Artegraft, known for its biologic vascular grafts used primarily in hemodialysis patients, generated $15.6 million in trade sales over the last year. This acquisition is expected to enhance LeMaitre's product offerings and profitability, positioning Artegraft as the largest product line in their sales portfolio. The deal will be funded through cash and a $65 million credit facility.
LeMaitre Vascular, Inc. (Nasdaq: LMAT) announced that CFO JJ Pellegrino will speak at the Jefferies Virtual Healthcare Conference on June 4, 2020, at 2:00 PM EDT. LeMaitre Vascular specializes in developing and marketing devices for peripheral vascular disease, which impacts over 200 million individuals globally. The company offers a range of disposable and implantable vascular devices for use by vascular surgeons. More details can be found on their website at www.lemaitre.com.
LeMaitre Vascular, listed on Nasdaq under the symbol LMAT, will be presented by President David Roberts at the UBS Virtual Global Healthcare Conference on May 20, 2020, at 8:20 AM EDT. The company specializes in developing and marketing devices for peripheral vascular disease, impacting over 200 million people globally. Their extensive product range focuses on disposable and implantable vascular devices tailored for vascular surgeons, enhancing treatment options for patients.